Company Profile

Aeon Imaging LLC
Profile last edited on: 12/5/2019      CAGE: 4NUT2      UEI: DLCKKJYC7NK3

Business Identifier: Cost eective diabetic retinopathy screening: embed low cost /robust imagers in telemedicine system with modern IT architecture to maximize screening throughput and retain patients through screening/referral process.
Year Founded
2005
First Award
2008
Latest Award
2022
Program Status
Active
Popularity Index
Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.

Location Information

501 South Madison Street Suite 103
Bloomington, IN 47403
   (812) 822-2048
   N/A
   www.aeonimaging.com
Location: Single
Congr. District: 09
County: Monroe

Public Profile

Aeon Imaging LLC is medical device company developing imaging systems for diabetic retinopathy screening, low vision assessment, biomedical imaging and spectroscopy. The firm's core technology came out of a collaboration with researchers at the Schepens Eye Research Institute and the Indiana University School of Optometry. This technology exploits the flexible electronic aperture inherent in current CMOS sensors in order to perform unique confocal imaging. Aeon Imaging is currently developing two retinal imaging cameras for wide-spread screening of retinal disease and low vision assessment. The first camera technology, the Laser Scanning Digital Camera (LSDC), is a low-cost, easy to use confocal line-scanning laser ophthalmoscope that records images of the back of the eye. The LSDC can finely adjust the offset of its confocal aperture with respect to the illumination light on the retina electronically in real-time. With a confocal aperture offset, the LSDC records images composed of multiply scattered light from the deeper layers of the retina, while rejecting the much stronger direct backscatter from superficial layers. The result is increased sensitivity to scattering defects such as drusen and to the presence of edema. The LSDC’s illumination source is more commonly used in telecommunication applications that require intensity modulation. In structured illumination mode, the source is modulated while imaging, producing a sequence of stripes across the image. The contrast or amplitude of the stripes measured through-focus provides a localized point-spread function. When measured near the fovea, this mode provides auto-focus; when combined with peripheral point-spread function measurements, the topography of the focused light on the retina can be reconstructed. Common uses for topography include modeling peripheral refraction and detecting retinal thickening commonly associated with eye disease. The second camera technology, the Digital Light Ophthalmoscope (DLO) achieves its small size and low cost using a digital light projector (DLP) as the imaging source. A series of lines are rapidly projected onto the retina to simulate line scanning. Light return is spatially filtered by the electronic rolling shutter of a CMOS sensor to achieve high contrast confocal imaging.

Extent of SBIR involvement

User Avatar

Synopsis: Awardee Business Condition

Employee Range
5-9
Revenue Range
.5M-1M
VC funded?
No
Public/Private
Privately Held
Stock Info
----
IP Holdings
1-4

Awards Distribution by Agency

Most Recent SBIR Projects

Year Phase Agency Total Amount
2023 2 NIH $1,585,525
Project Title: Visual Acuity and Functional Measurements in the Aging Eye
2019 2 NIH $1,387,702
Project Title: Confocal and Autofluorescence Imaging of Macular Degeneration Using a Low Cost DI
2018 1 NIH $223,898
Project Title: Tissue Oxygenation in Small Retinal Vessels
2017 1 NIH $99,500
Project Title: Assistive Device to Improve Object Recognition and Reading
2015 1 NIH $221,519
Project Title: Lowering the Cost of Imaging for Retinal Microvasculature in Diabetic Patients

Key People / Management

  Ann E Elsner -- Chief Executive Officer

  Thomas J Gast -- Chief Medical Officer

  Allen Ingling -- Project Manager, Vision Science Market

  Matthew S Muller -- Chief Operating Officer

  Benno L Petrig -- Chief Scientific Officer